REQUEST A DEMO
Total
USD $0.00
Search more companies

Synteq Medical Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Synteq Medical Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Synteq Medical Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Puchong. The enterprise currently operates in the Pharmacies and Drug Stores sector. The company was established on September 23, 2008. It currently has a total number of 10 (2023) employees. The latest financial highlights indicate a net sales revenue increase of 12.79% in 2022. Over the same period, its total assets grew by 7.22%. In 2022, Synteq Medical Sdn. Bhd.’s net profit margin increased by 1.15%.

Headquarters
No 17A & 17B, Jalan Bp 7/12, Bandar Bukit Puchong
Puchong; Selangor; Postal Code: 47120

Contact Details: Purchase the Synteq Medical Sdn. Bhd. report to view the information.

Basic Information
Total Employees:
Purchase the Synteq Medical Sdn. Bhd. report to view the information.
Outstanding Shares:
Purchase the Synteq Medical Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Synteq Medical Sdn. Bhd. report to view the information.
Incorporation Date:
September 23, 2008
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Synteq Medical Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
12.79%
Total operating revenue
12.79%
Operating profit (EBIT)
29.49%
EBITDA
22.31%
Net Profit (Loss) for the Period
36.87%
Total assets
7.22%
Total equity
44.7%
Operating Profit Margin (ROS)
1.07%
Net Profit Margin
1.15%
Return on Equity (ROE)
-1.54%
Debt to Equity Ratio
-101.12%
Quick Ratio
0.27%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?